EP 287: Harnessing AI Technologies for Next-Generation Clinical Trials

Send Everyday AI and Jordan a text message

Clinical trials can sometimes take years and cost many of millions of dollars. Why is that? And how can AI help bring faster and better outcomes?  Saurabh Jain, Executive Chairman at TrialKey.ai,  joins us to discuss how we can harness AI for clinical trials.
 
Newsletter: Sign up for our free daily newsletter
More on this Episode: Episode Page
Join the discussion: Ask Jordan and Saurabh questions on AI in clinical trials

Related Episode: Ep 107: How AI Turns Clinical Trials into Medical Knowledge

Upcoming Episodes: Check out the upcoming Everyday AI Livestream lineup
Website: YourEverydayAI.com
Email The Show: [email protected]
Connect with Jordan on LinkedIn

Topics Covered in This Episode:
1. State and Limitations of Traditional Clinical Trials
2. Role of Generative AI in Modern Drug Development
3. AI in Clinical Trials
4. Exploring ChatGPT in Clinical Trials

Timestamps:
01:30 Daily AI news
04:20 About Saurabh and TrialKey.ai
09:33 ChatGPT transforms unstructured data to structured.
10:43 Addressing hallucinations, incomplete datasets, and novel drugs.
15:16 Challenges in drug development and commercialization balancing.
18:30 Challenges of AI in research investment and focus.
24:15 Balancing AI and human ethics in medicine.
28:23 AI's potential in clinical trials, despite challenges.

Keywords:
Generative AI, clinical trials, advanced AI, drug discovery, Treatment Market, AI news, Elon Musk, NVIDIA GPU chips, Tesla, XAI, US Treasury, Janet Yellen, Saurabh Jain, Trial Key AI,Large language model, COVID-19, drug development, Jordan Wilson, AI simulations, drug market approval, FDA regulations, GPT technology, chat GPT, AI computer technology, pharmaceutical companies, machine learning, rare diseases, trial design, phase 3 trials, trial success prediction.

Ready for ROI on GenAI? Go to youreverydayai.com/partner